Organ-on-a-chip Market Driven by Drug Discovery and Development Needs

Drug discovery and development applications are key drivers of the Organ-on-a-chip Market. Traditional in vitro and animal models often fail to predict human responses accurately, leading to high drug attrition rates during clinical trials.

Market analysis of the Organ-on-a-chip Market highlights growing adoption of these platforms for toxicity screening, efficacy testing, and pharmacokinetic studies. By providing human-relevant data earlier in the development process, organ-on-a-chip systems help pharmaceutical companies improve decision-making and reduce development risks.

FAQs

1. How does organ-on-a-chip help drug development?
It improves prediction of human drug responses.

2. Can it reduce clinical trial failures?
Yes, by identifying toxicity and inefficacy earlier.

3. Is it used alongside animal testing?
Yes, it often complements existing models.